United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $547.62, for a total value of $5,202,390.00. Following the completion of the sale, the chief executive officer owned 40,513 […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) EVP Paul Mahon sold 8,300 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $547.07, for a total value of $4,540,681.00. Following the completion of the sale, the executive vice president owned 45,172 shares in the […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $547.61, for a total value of $5,202,295.00. Following the sale, the chief executive officer directly owned 40,513 shares in the company, valued […]

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) major shareholder James Peyer sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $20.02, for a total transaction of $500,500.00. Following the sale, the insider owned 130,142 shares of the company’s […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $572.94, for a total value of $5,729,400.00. Following the sale, the chief financial officer directly owned 18,876 shares in the company, […]